A comprehensive 2025 analysis published in the Proceedings of the National Academy of Sciences (PNAS) evaluated patient-reported outcomes for various treatments in post-viral dysautonomia and ME/CFS cohorts
Cost and access considerations : Wegovy is currently available through the NHS in limited circumstances according to NICE guidance and may require private prescription for many patients
If anything looks off, contact the pharmacy before using it
Patients who are treated with GLP-1s tend to discontinue at a relatively high rate
Common adverse reactions include nausea, diarrhea, vomiting, constipation, and abdominal discomfort, typically diminishing as the body adapts to the medication
TB-500 (10mg) a synthetic version of Thymosin Beta-4, a naturally occurring peptide found in virtually all human and animal cells